Baxter Issues Voluntary Nationwide Recall For One Lot Of 70% Dextrose Injection Due To Potential Presence Of Particulate Matter

Recall Summary Baxter is recalling one lot of 70% Dextrose Injection because stainless steel particles may be present in the solution. This product is used as an intravenous injection. The recall affects all consumers who received or have this specific lot of the medication.

Recalling firm

Baxter

Product

for One Lot of 70% Dextrose Injection

Reason

FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate matter identified as stainless steel particles in the solution.

Category

drug recall

Country

United States

Agency

FDA-MEDWATCH-RSS

Recall date

2026-08-25

Status

Ongoing

Official recall notice from FDA-MEDWATCH-RSS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b04d8277-4632-4d07-8c3c-e605c95787b1